Inventor
WEINSTEIN DAVID S
US36 patents
⚠️ This page may combine multiple inventors who share the name “WEINSTEIN DAVID S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
35 patentsUS9505748B2Nov 29, 2016
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO53 citations97
US6887870B1May 3, 2005
Heterocyclic sodium/proton exchange inhibitors and method
BRISTOL MYERS SQUIBB CO51 citations95
USRE47929EApr 7, 2020
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO19 citations94
US10000480B2Jun 19, 2018
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO20 citations94
US9663467B2May 30, 2017
Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO21 citations93
US7326705B2Feb 5, 2008
Heterocyclic sodium/proton exchange inhibitors and method
BRISTOL MYERS SQUIBB CO24 citations92
US11021475B2Jun 1, 2021
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO8 citations84
US11021462B2Jun 1, 2021
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
BRISTOL MYERS SQUIBB CO6 citations84
US9540333B2Jan 10, 2017
Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα
BRISTOL MYERS SQUIBB CO11 citations84
US9987266B2Jun 5, 2018
Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO9 citations83
US9315494B2Apr 19, 2016
Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO14 citations83
US11787779B2Oct 17, 2023
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
BRISTOL MYERS SQUIBB CO2 citations73
US10294256B2May 21, 2019
Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO5 citations73
US10273237B2Apr 30, 2019
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses
BRISTOL MYERS SQUIBB CO4 citations73
US7253283B2Aug 7, 2007
Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO6 citations73
US7351727B2Apr 1, 2008
Inhibitors of 15-lipoxygenase
BRISTOL MYERS SQUIBB CO4 citations63
US12365667B2Jul 22, 2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
BRISTOL MYERS SQUIBB CO0 citations62
US8034940B2Oct 11, 2011
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO4 citations62
US7888381B2Feb 15, 2011
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
BRISTOL MYERS SQUIBB CO6 citations62
US11597721B2Mar 7, 2023
Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO1 citations59
US10479793B2Nov 19, 2019
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO1 citations59
US12528782B2Jan 20, 2026
Prodrugs in the modulation of interleukin
BRISTOL MYERS SQUIBB CO0 citations56
US12479831B2Nov 25, 2025
Substituted N(-methyl-D3)pyridazine-3-carboxamide or M-(methyl-D3)-nicotinamide compounds as IL-12, IL-23 and/or IFNα modulators
BRISTOL MYERS SQUIBB CO0 citations52
US11299494B2Apr 12, 2022
Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators
BRISTOL MYERS SQUIBB CO0 citations52
US10781215B2Sep 22, 2020
Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO0 citations52
US7534804B2May 19, 2009
Benzoxazole inhibitors of 15-lipoxygenase
BRISTOL MYERS SQUIBB CO0 citations52
US7432271B2Oct 7, 2008
Pyrazolyl inhibitors of 15-lipoxygenase
BRISTOL MYERS SQUIBB CO1 citations52
US7544808B2Jun 9, 2009
Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO0 citations51
US9796720B2Oct 24, 2017
Imidazole-derived modulators of the glucocorticoid receptor
BRISTOL MYERS SQUIBB CO0 citations41
US9725443B2Aug 8, 2017
RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations41
US9663469B2May 30, 2017
RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations41
US9593113B2Mar 14, 2017
Imide and acylurea derivatives as modulators of the glucocorticoid receptor
BRISTOL MYERS SQUIBB CO0 citations41
US7317032B2Jan 8, 2008
Imidazolyl inhibitors of 15-lipoxygenase
BRISTOL MYERS SQUIBB CO0 citations41
US7605264B2Oct 20, 2009
Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO0 citations40
US7429611B2Sep 30, 2008
Indole inhibitors of 15-lipoxygenase
BRISTOL MYERS SQUIBB CO0 citations40